Caladrius Biosciences, Inc. (LSTA) Tops Q1 EPS by 14c

Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q1 EPS of ($0.65), $0.14 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Is Treasury selloff a major issue for stock market bulls?
• L3Harris CEO steps down amid conduct review, shares drop